BERKELEY, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call on Wednesday, May 7, 2014, at 4:30 p.m. Eastern time to discuss first quarter 2014 financial results and provide an update on gevokizumab's global clinical programs.
Help employers find you! Check out all the jobs and post your resume.
